vs
CAVA GROUP, INC.（CAVA）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
CAVA GROUP, INC.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$280.6M vs $207.3M），CAVA GROUP, INC.净利率更高（6.5% vs -62.0%，领先68.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 20.2%），CAVA GROUP, INC.自由现金流更多（$19.2M vs $-100.8M）
Cava是美国知名地中海风味休闲快餐连锁品牌，隶属于上市企业Cava集团。2018年8月集团收购Zoës Kitchen后，成为美国餐饮行业地中海品类规模最大的运营商。除餐厅业务外，集团还生产地中海风味蘸酱、抹酱、沙拉酱等产品，在全美各大商超渠道发售。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CAVA vs RARE — 直观对比
营收规模更大
CAVA
是对方的1.4倍
$207.3M
营收增速更快
RARE
高出5.7%
20.2%
净利率更高
CAVA
高出68.6%
-62.0%
自由现金流更多
CAVA
多$120.0M
$-100.8M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $280.6M | $207.3M |
| 净利润 | $18.4M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 7.0% | -54.7% |
| 净利率 | 6.5% | -62.0% |
| 营收同比 | 20.2% | 25.9% |
| 净利润同比 | -7.0% | 3.5% |
| 每股收益（稀释后） | $0.16 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAVARARE
| Q4 25 | — | $207.3M | ||
| Q3 25 | $280.6M | $159.9M | ||
| Q2 25 | $331.8M | $166.5M | ||
| Q1 25 | — | $139.3M | ||
| Q4 24 | — | $164.6M | ||
| Q3 24 | $233.5M | $139.5M | ||
| Q2 24 | $259.0M | $147.0M | ||
| Q1 24 | — | $108.8M |
净利润CAVARARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $18.4M | $-180.4M | ||
| Q2 25 | $25.7M | $-115.0M | ||
| Q1 25 | — | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $19.7M | $-133.5M | ||
| Q2 24 | $14.0M | $-131.6M | ||
| Q1 24 | — | $-170.7M |
毛利率CAVARARE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 26.7% | — | ||
| Q2 24 | 25.2% | — | ||
| Q1 24 | — | — |
营业利润率CAVARARE
| Q4 25 | — | -54.7% | ||
| Q3 25 | 7.0% | -106.9% | ||
| Q2 25 | 4.7% | -64.8% | ||
| Q1 25 | — | -102.6% | ||
| Q4 24 | — | -74.3% | ||
| Q3 24 | 6.9% | -94.6% | ||
| Q2 24 | 3.6% | -79.1% | ||
| Q1 24 | — | -151.9% |
净利率CAVARARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | 6.5% | -112.8% | ||
| Q2 25 | 7.7% | -69.0% | ||
| Q1 25 | — | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | 8.5% | -95.7% | ||
| Q2 24 | 5.4% | -89.5% | ||
| Q1 24 | — | -156.8% |
每股收益（稀释后）CAVARARE
| Q4 25 | — | $-1.28 | ||
| Q3 25 | $0.16 | $-1.81 | ||
| Q2 25 | $0.22 | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | — | $-1.34 | ||
| Q3 24 | $0.17 | $-1.40 | ||
| Q2 24 | $0.12 | $-1.52 | ||
| Q1 24 | — | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $290.2M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $750.7M | $-80.0M |
| 总资产 | $1.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CAVARARE
| Q4 25 | — | $421.0M | ||
| Q3 25 | $290.2M | $202.5M | ||
| Q2 25 | $289.4M | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | $343.7M | $150.6M | ||
| Q2 24 | $329.1M | $480.7M | ||
| Q1 24 | — | $112.3M |
股东权益CAVARARE
| Q4 25 | — | $-80.0M | ||
| Q3 25 | $750.7M | $9.2M | ||
| Q2 25 | $726.2M | $151.3M | ||
| Q1 25 | — | $144.2M | ||
| Q4 24 | — | $255.0M | ||
| Q3 24 | $595.4M | $346.8M | ||
| Q2 24 | $580.8M | $432.4M | ||
| Q1 24 | — | $140.3M |
总资产CAVARARE
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $1.0B | $1.5B | ||
| Q2 24 | $1.0B | $1.6B | ||
| Q1 24 | — | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $19.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 6.8% | -48.6% |
| 资本支出强度资本支出/营收 | 14.7% | 0.5% |
| 现金转化率经营现金流/净利润 | 3.28× | — |
| 过去12个月自由现金流最近4个季度 | $49.3M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流CAVARARE
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $60.3M | $-91.4M | ||
| Q2 25 | $38.6M | $-108.3M | ||
| Q1 25 | — | $-166.5M | ||
| Q4 24 | — | $-79.3M | ||
| Q3 24 | $48.9M | $-67.0M | ||
| Q2 24 | $38.4M | $-77.0M | ||
| Q1 24 | — | $-190.7M |
自由现金流CAVARARE
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $19.2M | $-92.7M | ||
| Q2 25 | $2.7M | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | $22.7M | $-68.6M | ||
| Q2 24 | $4.7M | $-79.0M | ||
| Q1 24 | — | $-193.9M |
自由现金流率CAVARARE
| Q4 25 | — | -48.6% | ||
| Q3 25 | 6.8% | -58.0% | ||
| Q2 25 | 0.8% | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | 9.7% | -49.2% | ||
| Q2 24 | 1.8% | -53.7% | ||
| Q1 24 | — | -178.2% |
资本支出强度CAVARARE
| Q4 25 | — | 0.5% | ||
| Q3 25 | 14.7% | 0.8% | ||
| Q2 25 | 10.8% | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 11.2% | 1.2% | ||
| Q2 24 | 13.0% | 1.4% | ||
| Q1 24 | — | 3.0% |
现金转化率CAVARARE
| Q4 25 | — | — | ||
| Q3 25 | 3.28× | — | ||
| Q2 25 | 1.50× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 2.74× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAVA
| Restaurant Revenue | $278.2M | 99% |
| Rewards | $2.8M | 1% |
| CPG Revenue And Other | $2.4M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
